Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Acadia Pharmaceuticals has appointed Catherine Owen Adams to succeed Steve Davis as chief executive (CEO) and a member of its board of directors. 28 September 2024
Structure Therapeutics, a specialist in small molecule treatments for metabolic and pulmonary diseases, has announced key leadership appointments. 18 September 2024
Under pressure from certain shareholders, autoimmune diseases specialist Aurinia Pharmaceuticals on Friday said it has restructured its board of directors. 14 September 2024
California’s Lykos Therapeutics is still trying to regroup after being rocked by the US Food and Drug Administration’s (FDA) rejection of midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD). 6 September 2024
Novocure (Nasdaq: NVCR) has announced that chief executive Asaf Danziger will retire at the end of 2024, with current chief financial officer Ashley Cordova set to succeed him as CEO. 4 September 2024
Lykos Therapeutics has announced a reorganization to best support the company as it works to address the resubmission of its new drug application (NDA) for midomafetamine capsules for the treatment of post-traumatic stress disorder (PTSD) in adults. 16 August 2024
German infectious disease specialist AiCuris Anti-infective Cures has announced the appointment of Cynthia Wat as chief medical officer (CMO). 30 July 2024
Ophirex, a registered public benefit corporation developing an oral field treatment to address the global unmet medical needs of snakebite victims, has announced the appointment of Jeremy Gowler as chief executive. 15 July 2024
US drugmaker AbbVie has announced that Roopal Thakkar, who currently serves as senior vice president, chief medical officer, global therapeutics, has been appointed to the position of executive vice president, research and development, and chief scientific officer (CSO). 10 July 2024
France-headquartered biopharma firm Genfit has announced an executive reshuffle appointing Dr Dean Hum as president of Genfit Corp and Dr Suneil Hosmane as head of Global Diagnostics. 27 September 2019
Hisamitsu Pharmaceutical subsidiary Noven Pharmaceuticals has appointed Naruhito Higo as chief executive, replacing Jeff Mihm, who has resigned. 24 September 2019
Spanish dermatology specialist Almirall has announced that Mike McClellan will join the company as new chief financial officer (CFO) on November 11, 2019. 18 September 2019
Danish allergy immunotherapy specialist ALK Abello today announced that Steen Riisgaard, ALK’s chairman, has informed the board of his intention to step down at the company's next Annual General Meeting (AGM), in March 2020. 13 September 2019
Shares of Swiss drugmaker Vifor Pharma edged up more that 2% to 159.40 Swiss francs today, after it announced changes to its management. 11 September 2019
Ireland-incorporated Horizon Therapeutics has named Andy Pasternak executive vice president, chief business officer, reporting directly to Timothy Walbert, chairman, president and chief executive officer, effective November 1. 29 August 2019
The big shoes of Sandra Horning, chief medical officer and head of global product development at Swiss pharma giant Roche, are to be filled by Levi Garraway. 19 August 2019
US pharma major Eli Lilly announced several leadership changes in the company's corporate business development, oncology R&D, and managed healthcare services organizations before markets opened this morning. 7 August 2019
US drugmaker Vertex Pharmaceuticals today revealed that its board has approved a planned transition of chairman, president and chief executive Dr Jeffrey Leiden, into the role of executive chairman of the board, effective April 1, 2020. 25 July 2019
Julian Gilbert, the founder of Anglo-American company Acacia Pharma Group, is to step down from his role as chief executive and director at the end of the month. 18 July 2019
After the failure of its latest drug candidate in clinical trials, US oncology specialist Merrimack Pharmaceuticals has issued a document to the US Securities and Exchange Commission, announcing the departure of the company’s top two executives. 4 July 2019
Ever since Dr Scott Gottlieb unexpectedly stepped down as head of the US Food and Drug Administration in March this year, less than two years into his tenure, there has been speculation about where he would re-appear 28 June 2019
Valo Therapeutics, a cancer immunotherapy company developing neoantigen-coated oncolytic viruses as therapeutic vaccines, has appointed Dr Michael Stein to the full-time role of chief executive, having served as part-time co-chairman since inception in January 2017. 17 June 2019
UK developer of inhaled therapeutics Vectura today announces that James Ward-Lilley will be stepping down from the Board and his position as chief executive on June 30, 2019. 10 June 2019
In a surprise announcement, French pharma major Sanofi has revealed that chief executive Olivier Brandicourt will retire in September, to be replaced by Novartis’ current pharma chief, Paul Hudson. 7 June 2019